Quick Answer
AtriCure, Inc. reported Revenue (ASC 606) of $534.53 million for fiscal year 2025.
AtriCure, Inc. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $534.53M | +14.9% |
| 2024 | $465.31M | +16.5% |
| 2023 | $399.25M | +20.8% |
| 2022 | $330.38M | +20.4% |
| 2021 | $274.33M | +32.8% |
| 2020 | $206.53M | -10.5% |
| 2019 | $230.81M | +14.5% |
| 2018 | $201.63M | +15.4% |
| 2017 | $174.72M | +12.6% |
| 2016 | $155.11M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $134.27M | +15.8% | -1.4% |
| June 30, 2025 | $136.14M | +17.1% | +10.1% |
| March 31, 2025 | $123.62M | +13.6% | +6.7% |
| September 30, 2024 | $115.91M | +17.9% | -0.3% |
| June 30, 2024 | $116.27M | +15.2% | +6.8% |
| March 31, 2024 | $108.85M | +16.4% | +10.7% |
| September 30, 2023 | $98.29M | +18.1% | -2.6% |
| June 30, 2023 | $100.92M | +19.4% | +7.9% |
- AtriCure, Inc. showed an increase of +14.9% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2016–2025 period, AtriCure, Inc.’s revenue (asc 606) has grown by 244.6% (from $155.11 million to $534.53 million).
- The most recent figure is from AtriCure, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: